What is the management for stomatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Management of stomatitis involves a combination of symptomatic relief and treating the underlying cause, with the most recent guidelines recommending the use of steroid mouthwash for prevention of stomatitis induced by mTOR inhibitors 1. The management approach should prioritize good oral hygiene using gentle brushing and alcohol-free mouthwashes. For pain relief, topical anesthetics like lidocaine 2% viscous solution or benzocaine gel can be applied to affected areas before meals. Anti-inflammatory rinses such as 0.12% chlorhexidine gluconate or salt water (1/2 teaspoon salt in 8 ounces warm water) used 3-4 times daily help reduce inflammation. Some key points to consider in the management of stomatitis include:

  • Preventive measures such as eliminating sources of trauma and avoiding painful stimuli like hot foods and drinks, and hard, sharp, or spicy foods 1
  • The use of oral care protocols to prevent oral mucositis in all age groups and across all cancer treatment modalities 1
  • Dietary modifications to avoid irritating the mucosa, opting for soft, bland foods, and staying hydrated
  • Consideration of nutritional supplements if eating is difficult
  • Targeted treatments for specific types of stomatitis, such as antifungal medications for candidal stomatitis, antivirals for herpetic stomatitis, and medication adjustments for drug-induced cases
  • The potential role of systemic analgesics like acetaminophen or NSAIDs for significant pain, and the use of topical corticosteroids like triamcinolone acetonide 0.1% dental paste for moderate to severe cases 1. Given the most recent evidence, the use of steroid mouthwash, such as 0.5 mg/5 ml dexamethasone, is recommended for the prevention of stomatitis induced by mTOR inhibitors 1. Early intervention is also recommended, and for grade >2 stomatitis, delaying treatment until the toxicity resolves and considering lowering the dose of the targeted agent are also suggested 1.

From the FDA Drug Label

INDICATIONS AND USAGE Nystatin Oral Suspension, USP, is indicated for the treatment of candidiasis in the oral cavity. DOSAGE AND ADMINISTRATION Infants: 2 mL (200,000 units) four times daily (in infants and young children, use dropper to place one-half of dose in each side of mouth and avoid feeding for 5 to 10 minutes). The management for stomatitis caused by candidiasis includes the use of nystatin oral suspension. The dosage is as follows:

  • Infants: 2 mL (200,000 units) four times daily
  • Children and Adults: 4 to 6 mL (400,000 to 600,000 units) four times daily Treatment should be continued for at least 48 hours after perioral symptoms have disappeared and cultures demonstrate eradication of Candida albicans 2 2

From the Research

Management of Stomatitis

The management of stomatitis can be achieved through various treatment options, including:

  • Topical medications such as corticosteroids (triamcinolone acetonide), anti-inflammatory drugs (amlexanox), antibiotics (doxycycline), and antiseptics (lidocaine) 3
  • Systemic drugs such as corticosteroids (prednisone), immunomodulatory drugs (thalidomide), and antibiotics/antimicrobials (clofazimine) for more severe cases 3
  • Dexamethasone mouthwash formulation, which has been shown to be effective in managing stomatitis in cancer patients 4, 5

Treatment Options for Specific Types of Stomatitis

  • For denture stomatitis, nystatin and disinfecting agents have been found to be effective in reducing clinical signs of stomatitis and mycological assessment 6
  • For oral candidiasis, nystatin pastille has been shown to be significantly superior to placebo in treating denture stomatitis, while nystatin suspension was not superior to fluconazole in treating oral candidiasis in infants, children, or HIV/AIDS patients 7

Key Considerations

  • The choice of treatment option depends on the severity of the stomatitis and the individual patient's circumstances 3
  • Clinicians should be aware of the potential risks and benefits of each treatment option, as well as the quality of the evidence supporting their use 6, 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.